Patient-groups' experiences of the Covid 2020 pandemic
Benchmarking 1,720 patient organisations worldwide on their experiences of the Covid pandemic
Neurology report - Corporate Reputation of Pharma 2019 now available
Benchmarking the pharmaceutical companies’ levels of patient centricity from a patient perspective
Rare-Diseases Report - Corporate Reputation of Pharma 2019 now available
Benchmarking pharmaceutical companies' levels of patient centricity - from a patient perspective
What we do
We work with the most important forces in healthcare: the Patient Movement.
PatientView undertakes regular evidence-based research into the different perspectives of patient organisations around the world on a range of issues. PatientView’s reach among these patient organisations is unique, with as many as 40,000 such groups in our informal network.
Patient organisations are in a unique position to provide valuable insights since they are the only stakeholder to interact across every aspect of the healthcare system: from regulators, physicians, healthcare providers, healthcare payers, and of course patients. Patient organisations hold strong views not only about the experiences and needs of patients with whom they are familiar, but on their country’s healthcare policies and systems, the value of technologies (including digital and mobile), and even the reputational status of the various agencies that make healthcare. Across our 20 year history, PatientView has collated evidence-based feedback on all these important subjects. Today, our most high-profile product concerns the corporate reputation of the pharmaceutical industry (from the perspective of patient groups). The product helps pharma develop and improve their strategies to build robust relationships with their ultimate customers, patients - and of course patient groups.
The Annual Survey of patient groups' perception of the pharmaceutical industry.
Being Patient Centric
What patient groups need and expect from pharma. A toolkit with deep-dive reports.
Quantitative survey assessing the strengths and weaknesses of the patient movement.
Mental-health patient groups have become increasingly dissatisfied with the pharmaceutical industry, according to our latest analysis of Corporate Reputation 2019.
Patient group experiences of the Covid 2020 pandemic The views of 1,720 patient groups Published: September 29th, 2020 ‘The experience of PATIENT ORGANISATIONS during the Covid-19 global pandemic’—Surveying in progress:… Continue reading “Covid-19 Survey”
How Covid-19 has affected patient groups.
How Covid-19 has affected patient groups. The publishing of this report, from surveying over 1,200 patient groups worldwide, is planned for September 2020
My health apps
Bringing together the world’s favourite healthcare apps – tried and tested by people like you
Launched in November 2013, MHA is developed and maintained by PatientView. The website curates hundreds of health apps tried and recommended by patient & health consumer groups worldwide.